US FDA Gains Budget Increase In FY 2017…And Not Through Fees

Omnibus legislation to fund the federal government for the remainder of FY 2017 includes a switch from what has been a growing trend of FDA's increasing reliance on industry user fees as opposed to congressional appropriations. Non-user-fee budget authority will grow, while fee amounts dropped for the fiscal year.

FDASignBldg21Entrance_1200x675

More from Legislation

More from Policy & Regulation